MORGAN STANLEY PLC/CALL/STRYKER CORP./430/0.1/20.09.24 Stock

Warrant

DE000ME9BQD8

Market Closed - Börse Stuttgart 02:15:07 2024-05-31 pm EDT
0.111 EUR -5.93% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./430/0.1/20.09.24
1 month-29.30%
3 months-69.17%
Date Price Change
24-05-31 0.111 -5.93%
24-05-30 0.118 -.--%
24-05-29 0.118 +22.92%
24-05-28 0.096 +6.67%
24-05-27 0.09 -12.62%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 02:15 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME9BQD
ISINDE000ME9BQD8
Date issued 2024-02-27
Strike 430 $
Maturity 2024-09-20 (110 Days)
Parity 10 : 1
Emission price 0.42
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.56
Lowest since issue 0.04
Delta0.07x
Omega 16.72
Premium26.69x
Gearing233.41x
Moneyness 0.7920
Difference Strike 89.43 $
Difference Strike %+20.80%
Spread 0.035
Spread %23.03%
Theoretical value 0.1345
Implied Volatility 25.73 %
Total Loss Probability 94.59 %
Intrinsic value 0.000000
Present value 0.1345
Break even 431.46 €
Theta-0.02x
Vega0.02x
Rho0.01x

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus